Multiple Myeloma Hub
The Multiple Myeloma Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in multiple myeloma. Our aim is to enhance knowledge in multiple myeloma through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management.The Multiple Myeloma Hub shares new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage to treatment teams and researchers around the world.
- 19:41
- 9 сағат бұрын
Symposium | Next wave of immune-based therapies: What you need to know, which focused on R/R MM
- 23:53
- 21 сағат бұрын
Symposium | How to sequence CAR T-cell therapy and bispecific antibodies in R/R multiple myeloma
- 4:16
- 14 күн бұрын
Iberdomide - efficacy and safety in RRMM
- 18:52
- Ай бұрын
Infections associated with bispecific antibodies
- 6:12
- 3 ай бұрын
What is the rationale for monitoring secondary malignancies after BCMA and CD19 CAR T-cell therapy?
- 22:48
- 4 ай бұрын
Symposium | BCMA-directed bispecific antibodies
- 9:08
- 4 ай бұрын
Symposium | Q&A session
- 7:06
- 4 ай бұрын
What factors contribute to resistance to BCMA-targeted CAR T-cell therapies in multiple myeloma?
- 8:06
- 6 ай бұрын
How do response rates observed in clinical trials translate into real-world outcomes in MM?
- 15:58
- 8 ай бұрын
Пікірлер